Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
"There's no data showing that people regained when they stayed on the medication." However, a 2022 study found that people who stopped taking it gained back about two-thirds of the weight they had lost
Want to start your weight loss journey
Wegovys manufacturer is also being sued by patients who say Novo Nordisk should have told them that NAION (which causes vision loss) could occur when taking Wegovy
Disclosures SELECT was funded by Novo Nordisk
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1) New England Journal of Medicine 384(11) 2021PMID: 33567185 NEJM 3 U.S
US$ 26.87
US$ 25.49
US$ 27.75
US$ 22.80
